Catégories
> Pathologie > Pathologie de l'appareil digestif > Pathologie Intestin > Maladie de Crohn
Maladie de Crohn |
Documents disponibles dans cette catégorie (6)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : texte imprimé
Most drugs used in the treatment of inflammatory bowel disease are compatible with breastfeeding. One exception is tofacitinib that requires cessation of breastfeeding if it is used. The use of weekly methotrexate is controversial. Although no a[...]Article : texte imprimé
Palika Datta, Auteur ; Kathleen Rewers-Felkins, Auteur ; Raja Reddy Kallem, Auteur |Background: Oral mesalamine (5-amino salicylic acid [5-ASA]) is an anti-inflammatory agent commonly used to treat inflammatory bowel disease such as ulcerative colitis and Crohn's disease. The transfer of mesalamine into human milk has to date b[...]Article : texte imprimé
Rob Knight, Auteur |The human body is made up of more microbial cells than human cells (43% versus 57%), and microbial genes outnumber human genes by about 100 to 1 (99% versus 1%). The microbiome plays an essential role in human health and disease and can impact r[...]Article : texte imprimé
Peter Gerrit Johannes ter Horst, Auteur ; Elise J. Smolders, Auteur ; Daphne den Besten-Bertholee, Auteur |A 35-year-old pregnant woman visited our outpatient clinical questioning the safety of once daily 50 mg mercaptopurine (MP) during pregnancy and lactation, which was successfully treating her Crohn's disease. We measured MP and its metabol[...]Article : texte imprimé
Teresa E. Baker, Auteur ; Shaun D. Cooper, Auteur ; Lacy Kessler, Auteur |Natalizumab (Tysabri) is a recombinant humanized antibody to α4-integrin that is approved by the Food and Drug Administration for the treatment of multiple sclerosis (MS) and Crohn disease. This is a case report of a 28-year-old woman with [...]